Characterization of Oxacillinase and Metallo-β-Lactamas Genes and Molecular Typing of Clinical Isolates of Acinetobacter Baumannii in Ahvaz, South-West of Iran

Overview

Journal Jundishapur J Microbiol

Publisher Brieflands

Specialty Microbiology

Date 2016 Aug 20

PMID 27540456

Citations 10

Authors

Saeed Shoja

Mojtaba Moosavian

Soodabeh Rostami

Fariba Abbasi

Mohammad Amin Tabatabaiefar

Amir Peymani

Affiliations

Soon will be listed here.

Abstract

Background: Carbapenem resistant Acinetobacter baumannii is an important nosocomial pathogen associated with a variety of infections.

Objectives: The current study aimed to characterize the antimicrobial susceptibility, analyze the prevalence of oxacillinase and metallo-β-lactamase (MBL) genes and molecular typing of clinical isolates of A. baumannii.

Materials And Methods: A total of 124 non-repetitive isolates of A. baumannii were collected from various clinical specimens in two teaching hospitals in Ahvaz, south-west of Iran. Antimicrobial susceptibility test was carried out by disk diffusion method. The minimum inhibitory concentrations (MICs) of imipenem, meropenem, colistin and tigecycline were determined using E-test. To screen for MBL production, double disk synergy (DDs) test and MBL E-test were performed. The presence of bla OXA-23-like, bla OXA-24-like, bla OXA-51-like, bla OXA-58-like, bla VIM, bla IMP and bla SPM genes was assessed by polymerase chain reaction (PCR). To identify clonal relatedness, all isolates were subjected to repetitive sequence-based PCR (rep-PCR).

Results: Based on disk diffusion results, the highest rate of resistance was observed in rifampin (96.8%). Colistin and polymyxin-B were the most effective agents in vitro. According to the MIC results, the rate of resistance to imipenem, meropenem, colistin and tigecycline were 78.2%, 73.4%, 0.8% and 0, respectively. Metallo-β-lactamase production was positive in 42.3% and 79.4% of the isolates by DDs test and E-test, respectively. All isolates (100%) carried bla OXA-51-like gene. According to the results of multiplex PCR, bla OXA-23-like and bla OXA-24-like genes were detected in 85.6% and 6.2% of carbapenem resistant isolates, respectively. No bla OXA-58- like, bla VIM, bla IMP and bla SPM were detected. By rep-PCR, carbapenem resistant isolates were separated into six genotypes (A to F). Genotype A (30.9%) was the most prevalent (P value < 0.001). Genotypes B and C were found in 28.9% and 26.8% of the isolates, respectively.

Conclusions: The rate of carbapenem resistant A. baumannii isolates were high in this study. Since, bla OXA-58-like or MBL genes were not detected, it seems that resistance to carbapenems is related to bla OXA-23-like and bla OXA-24-like. Moreover, bla OXA-23-like was the most prevalent oxacillinase (OXA) gene. Most of the isolates belonged to one of the four dominant genotypes indicating clonal dissemination in the hospitals under study. In order to control the spread of carbapenem-resistant A. baumannii, infection- control strategies are needed.

Citing Articles

Identification of bla, bla, bla, and bla carbapenemase genes in Acinetobacter baumannii isolates from hospitalized patients.

Nasrabadi K, Ahmadi Y, Ghasemi S, Shokri D BMC Res Notes. 2024; 17(1):392.

PMID: 39736661 PMC: 11684280. DOI: 10.1186/s13104-024-07047-5.

Application of bacteriophage cocktails for reducing the bacterial load of nosocomial pathogens in hospital wastewater.

Sadeqi S, Hashemi Shahraki A, Nikkhahi F, Javadi A, Marashi S Iran J Microbiol. 2023; 14(3):395-401.

PMID: 37124863 PMC: 10132342. DOI: 10.18502/ijm.v14i3.9782.

Molecular Characterization of Carbapenem-Resistant Isolated from the Intensive Care Unit in a Tertiary Teaching Hospital in Malaysia.

Woon J, Teh C, Chong C, Abdul Jabar K, Ponnampalavanar S, Idris N Antibiotics (Basel). 2021; 10(11).

PMID: 34827278 PMC: 8615160. DOI: 10.3390/antibiotics10111340.

Carbapenem resistance in clinical isolates from northwest Iran: high prevalence of OXA genes in sync.

Vahhabi A, Hasani A, Rezaee M, Baradaran B, Hasani A, Kafil H Iran J Microbiol. 2021; 13(3):282-293.

PMID: 34540166 PMC: 8416588. DOI: 10.18502/ijm.v13i3.6388.

Molecular survey of aminoglycoside-resistant isolated from tertiary hospitals in Qazvin, Iran.

Rashvand P, Peymani A, Mohammadi M, Karami A, Samimi R, Hajian S New Microbes New Infect. 2021; 42:100883.

PMID: 34094583 PMC: 8165567. DOI: 10.1016/j.nmni.2021.100883.

References

Peymani A, Farajnia S, Nahaei M, Sohrabi N, Abbasi L, Ansarin K . Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran. Pol J Microbiol. 2012; 61(1):57-60. View

Ben R, Yang M, Hsueh J, Shiang J, Chien S . Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan. Int J Antimicrob Agents. 2011; 38(5):403-8. DOI: 10.1016/j.ijantimicag.2011.05.014. View

Touati M, Diene S, Racherache A, Dekhil M, Djahoudi A, Rolain J . Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents. 2012; 40(1):89-91. DOI: 10.1016/j.ijantimicag.2012.03.017. View

Ece G, Erac B, Yurday Cetin H, Ece C, Baysak A . Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey. Jundishapur J Microbiol. 2015; 8(2):e15612. PMC: 4376970. DOI: 10.5812/jjm.15612. View

DArezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P . Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother. 2010; 66(1):54-61. PMC: 3031335. DOI: 10.1093/jac/dkq407. View

Snelling A, Gerner-Smidt P, Hawkey P, Heritage J, Parnell P, Porter C . Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a.... J Clin Microbiol. 1996; 34(5):1193-202. PMC: 228981. DOI: 10.1128/jcm.34.5.1193-1202.1996. View

Zong Z, Lu X, Valenzuela J, Partridge S, Iredell J . An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents. 2007; 31(1):50-4. DOI: 10.1016/j.ijantimicag.2007.08.019. View

Moosavian M, Shoja S, Nashibi R, Ebrahimi N, Tabatabaiefar M, Rostami S . Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii. Jundishapur J Microbiol. 2015; 7(10):e12287. PMC: 4295316. DOI: 10.5812/jjm.12287. View

Poirel L, Nordmann P . Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006; 12(9):826-36. DOI: 10.1111/j.1469-0691.2006.01456.x. View

10.

Kulah C, Mooij M, Comert F, Aktas E, Celebi G, Ozlu N . Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Int J Antimicrob Agents. 2010; 36(2):114-8. DOI: 10.1016/j.ijantimicag.2010.03.017. View

11.

Fontana C, Favaro M, Minelli S, Bossa M, Testore G, Leonardis F . Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect Dis. 2008; 8:79. PMC: 2443154. DOI: 10.1186/1471-2334-8-79. View

12.

Yan Z, Shen D, Cao J, Chen R, Wei X, Liu L . Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. Int J Antimicrob Agents. 2009; 35(3):269-73. DOI: 10.1016/j.ijantimicag.2009.10.016. View

13.

Carvalho K, DAlincourt Carvalho-Assef A, Peirano G, dos Santos L, Pereira M, Asensi M . Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2009; 34(1):25-8. DOI: 10.1016/j.ijantimicag.2008.12.009. View

14.

Irfan S, Turton J, Mehraj J, Siddiqui S, Haider S, Zafar A . Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J Hosp Infect. 2011; 78(2):143-8. DOI: 10.1016/j.jhin.2011.01.029. View

15.

Turton J, Ward M, Woodford N, Kaufmann M, Pike R, Livermore D . The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006; 258(1):72-7. DOI: 10.1111/j.1574-6968.2006.00195.x. View

16.

Sohrabi N, Farajnia S, Akhi M, Nahaei M, Naghili B, Peymani A . Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist. 2012; 18(4):385-9. DOI: 10.1089/mdr.2011.0077. View

17.

Karah N, Haldorsen B, Hermansen N, Tveten Y, Ragnhildstveit E, Skutlaberg D . Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. J Med Microbiol. 2010; 60(Pt 4):515-521. DOI: 10.1099/jmm.0.028340-0. View

18.

Purohit M, Mendiratta D, Deotale V, Madhan M, Manoharan A, Narang P . Detection of metallo-β-lactamases producing Acinetobacter baumannii using microbiological assay, disc synergy test and PCR. Indian J Med Microbiol. 2012; 30(4):456-61. DOI: 10.4103/0255-0857.103770. View

19.

Hu Q, Hu Z, Li J, Tian B, Xu H, Li J . Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China. J Basic Microbiol. 2011; 51(5):467-72. DOI: 10.1002/jobm.201000402. View

20.

Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A . Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries. 2009; 3(5):335-41. DOI: 10.3855/jidc.240. View